Unknown primary large-cell neuroendocrine tumor

Large-cell neuroendocrine tumors (NETs) are poorly differentiated malignancies of rare incidence and aggressive nature. NETs mostly arise in the lung followed by the gastrointestinal tract, although they are potentially ubiquitous throughout the body. Primary unknown NET has a worse prognosis and sh...

Full description

Bibliographic Details
Main Authors: Sara Póvoa, Daniela Azevedo, Cristiana Marques, Helena Barroca, Andreia Costa
Format: Article
Language:English
Published: University of São Paulo 2018-06-01
Series:Autopsy and Case Reports
Subjects:
Online Access:http://www.revistas.usp.br/autopsy/article/view/147188
_version_ 1830518269996433408
author Sara Póvoa
Daniela Azevedo
Cristiana Marques
Helena Barroca
Andreia Costa
author_facet Sara Póvoa
Daniela Azevedo
Cristiana Marques
Helena Barroca
Andreia Costa
author_sort Sara Póvoa
collection DOAJ
description Large-cell neuroendocrine tumors (NETs) are poorly differentiated malignancies of rare incidence and aggressive nature. NETs mostly arise in the lung followed by the gastrointestinal tract, although they are potentially ubiquitous throughout the body. Primary unknown NET has a worse prognosis and shorter survival comparing with other NETs, with limited available data in the literature concerning this subgroup. The authors report the case of large-cell NET with supraclavicular lymph node presentation. Total excisional biopsy revealed an enlarged adenopathy 18 × 15 × 10 mm, which was extensively infiltrated by a solid malignant neoplasm composed of large cells with granular chromatin, nuclear pseudo-inclusions, high mitotic index, and focal necrosis, with a Ki 67 index 25-30% and positive immunohistochemical study for the expression of cytokeratin 8/18, chromogranin, synaptophysin, and thyroid transcriptional factor-1 (TTF-1). There was no evidence of primary location apart from two infracentimetric lung lesions that could not be accessed for biopsy and were negative at both somatostatin receptor scintigraphy and positron emission tomography. The NET relapsed with three mediastinal masses, so the patient was started on chemotherapy with carboplatin and etoposide with initial total response. Early progression showed no response to further chemotherapy regimens (temozolomide, oral etoposide); therefore, the patient was treated with local radiotherapy. This patient has an atypical long survival (54 months) compared to the literature data. In fact, there are few long-term survivors of large-cell NET and they are all related to complete surgical resection.
first_indexed 2024-12-22T04:15:44Z
format Article
id doaj.art-1e0ed6279d8d40d6877d44618f1cecd0
institution Directory Open Access Journal
issn 2236-1960
language English
last_indexed 2024-12-22T04:15:44Z
publishDate 2018-06-01
publisher University of São Paulo
record_format Article
series Autopsy and Case Reports
spelling doaj.art-1e0ed6279d8d40d6877d44618f1cecd02022-12-21T18:39:24ZengUniversity of São PauloAutopsy and Case Reports2236-19602018-06-018210.4322/acr.2018.025Unknown primary large-cell neuroendocrine tumorSara Póvoa0Daniela Azevedo1Cristiana Marques2Helena Barroca3Andreia Costa4Centro Hospitalar de São João, Medical Oncology DepartmentCentro Hospitalar de São João, Medical Oncology DepartmentCentro Hospitalar de São João, Medical Oncology DepartmentCentro Hospitalar de São João, Pathology DepartmentCentro Hospitalar de São João, Medical Oncology DepartmentLarge-cell neuroendocrine tumors (NETs) are poorly differentiated malignancies of rare incidence and aggressive nature. NETs mostly arise in the lung followed by the gastrointestinal tract, although they are potentially ubiquitous throughout the body. Primary unknown NET has a worse prognosis and shorter survival comparing with other NETs, with limited available data in the literature concerning this subgroup. The authors report the case of large-cell NET with supraclavicular lymph node presentation. Total excisional biopsy revealed an enlarged adenopathy 18 × 15 × 10 mm, which was extensively infiltrated by a solid malignant neoplasm composed of large cells with granular chromatin, nuclear pseudo-inclusions, high mitotic index, and focal necrosis, with a Ki 67 index 25-30% and positive immunohistochemical study for the expression of cytokeratin 8/18, chromogranin, synaptophysin, and thyroid transcriptional factor-1 (TTF-1). There was no evidence of primary location apart from two infracentimetric lung lesions that could not be accessed for biopsy and were negative at both somatostatin receptor scintigraphy and positron emission tomography. The NET relapsed with three mediastinal masses, so the patient was started on chemotherapy with carboplatin and etoposide with initial total response. Early progression showed no response to further chemotherapy regimens (temozolomide, oral etoposide); therefore, the patient was treated with local radiotherapy. This patient has an atypical long survival (54 months) compared to the literature data. In fact, there are few long-term survivors of large-cell NET and they are all related to complete surgical resection.http://www.revistas.usp.br/autopsy/article/view/147188CarcinomaNeuroendocrineNeoplasmsUnknown PrimaryNeuroendocrine Tumors.
spellingShingle Sara Póvoa
Daniela Azevedo
Cristiana Marques
Helena Barroca
Andreia Costa
Unknown primary large-cell neuroendocrine tumor
Autopsy and Case Reports
Carcinoma
Neuroendocrine
Neoplasms
Unknown Primary
Neuroendocrine Tumors.
title Unknown primary large-cell neuroendocrine tumor
title_full Unknown primary large-cell neuroendocrine tumor
title_fullStr Unknown primary large-cell neuroendocrine tumor
title_full_unstemmed Unknown primary large-cell neuroendocrine tumor
title_short Unknown primary large-cell neuroendocrine tumor
title_sort unknown primary large cell neuroendocrine tumor
topic Carcinoma
Neuroendocrine
Neoplasms
Unknown Primary
Neuroendocrine Tumors.
url http://www.revistas.usp.br/autopsy/article/view/147188
work_keys_str_mv AT sarapovoa unknownprimarylargecellneuroendocrinetumor
AT danielaazevedo unknownprimarylargecellneuroendocrinetumor
AT cristianamarques unknownprimarylargecellneuroendocrinetumor
AT helenabarroca unknownprimarylargecellneuroendocrinetumor
AT andreiacosta unknownprimarylargecellneuroendocrinetumor